Literature DB >> 2616815

Neoadjuvant chemotherapy and irradiation in multiple synchronous squamous cell carcinoma of the upper aero digestive tract.

T D Nguyen1, X Panis, M Legros, L Demange, D Froissart, F Marechal.   

Abstract

Twenty-four patients with multiple, synchronous carcinoma of the head and neck, lung or esophagus, were treated with induction chemotherapy followed by irradiation to involved areas. Chemotherapy regimen consisted of cisplatinum either alone, or in combination with 5-FU or etoposide. Subsequently, external radiotherapy, 60-65 Gy and 70-75 Gy to the mediastinum and the head and neck areas, respectively, was carried out. Following chemotherapy, three patients (12.5%) had a complete clinical remission in both cervical and mediastinal sites. That rate was significantly increased by radiotherapy (66%). Tolerance was fair or mild even though half of the patients needed a rest break during irradiation. Follow-up ranges from 24 to 38 months. The median survival is 12 months and the actuarial survival rates are 45% and 5% at 12 and 24 months, respectively. It is suggested that induction chemotherapy will not drastically improve the overall prognosis of multiple squamous cell carcinoma of the upper aero digestive tract and that external irradiation remains a major part of treatment which should not be reduced in treated volumes, or in total dose delivered.

Entities:  

Mesh:

Year:  1989        PMID: 2616815     DOI: 10.1016/0167-8140(89)90040-6

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.

Authors:  Yasuhiko Hamada; Toshiro Mizuno; Kyosuke Tanaka; Masaki Katsurahara; Noriyuki Horiki; Reiko Yamada; Hiroyuki Inoue; Yoshiyuki Takei; Naoyuki Katayama
Journal:  Int J Clin Oncol       Date:  2017-10-24       Impact factor: 3.402

2.  Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Yan-Ye Su; Li-Hsueh Shih; Shau-Hsuan Li
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

3.  Chemoradiotherapy for Synchronous Multiple Primary Cancers with Esophageal Squamous Cell Carcinoma: a Case-control Study.

Authors:  Qi-Wen Li; Yu-Jia Zhu; Wen-Wen Zhang; Han Yang; Yao Liang; Yong-Hong Hu; Bo Qiu; Meng-Zhong Liu; Hui Liu
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

4.  Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Shau-Hsuan Li
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.